AI and HealthCare, Author Interviews, Brain Cancer - Brain Tumors, Lancet, Mammograms / 30.01.2026

MedicalResearch.com Interview with: [caption id="attachment_72182" align="alignleft" width="200"]Kristina Lång MD PhDAssociate professor, Diagnostic Radiology Translational Medicine, Lund University Senior consultant, Unilabs Mammography Unit Skåne University Hospital, Malmö, Sweden Dr. Lång[/caption] Kristina Lång MD PhD Associate professor, Diagnostic Radiology Translational Medicine, Lund University Senior consultant, Unilabs Mammography Unit Skåne University Hospital, Malmö, Sweden MedicalResearch.com: What is the background for this study? Response:  Prior to the start of the trial, several retrospective studies had shown that AI could discriminate between screening mammograms at low and high risk of cancer, with performance comparable to that of average breast radiologists. These findings suggested a potential to improve both the efficiency and sensitivity of mammography screening. This motivated us to design and evaluate an AI-supported screening procedure in a randomised controlled trial. The MASAI trial was among the first prospective studies in this field and, to date, remains the only randomised trial with reported results on the use of AI in breast cancer screening. In European breast cancer screening programmes, every mammogram is usually read by two radiologists, so called double reading, to ensure a high sensitivity. In the MASAI trial we compared AI-supported mammography screening to standard double reading without AI. I n the AI-supported approach, mammograms identified as low-risk by the AI were read by a single radiologist, while high-risk mammograms underwent double reading, with AI providing additional detection support.
Breast Cancer / 29.07.2025

Each October brings a wave of pink ribbons and powerful reminders about the importance of breast cancer awareness. Campaigns promoting early detection through mammograms have undoubtedly saved lives, but beneath the surface, many individuals still quietly face obstacles that prevent them from getting screened. These barriers are often overlooked, yet they carry serious consequences. Barriers Beyond the Calendar Scheduling a mammogram may seem simple, but the reality is often much more complex. For many, there are hidden layers of stress, confusion, and logistical difficulty. Language differences, cultural norms, limited transportation, or lack of childcare can all stand in the way of following through with a screening. People new to the healthcare system may not even know how to begin the process or where to go. Emotional and mental health challenges also play a significant role. Anxiety about medical settings, concerns over body image, or past negative healthcare experiences can discourage someone from seeking help. For some, the fear of a potential diagnosis becomes a powerful reason to avoid screenings altogether. These personal and psychological hurdles are just as important to acknowledge as physical and financial limitations.
Author Interviews, Breast Cancer, JAMA, Race/Ethnic Diversity / 25.04.2023

MedicalResearch.com Interview with: [caption id="attachment_60348" align="alignleft" width="200"]Mahdi Fallah, MD, PhD Study and Group Leader Risk Adapted Prevention (RAD) Group Division of Preventive Oncology National Center for Tumor Diseases (NCT) German Cancer Research Center (DKFZ) Heidelberg, Germany Dr. Fallah[/caption] Mahdi Fallah, MD, PhD Study and Group Leader Risk Adapted Prevention (RAD) Group Division of Preventive Oncology National Center for Tumor Diseases (NCT) German Cancer Research Center (DKFZ) Heidelberg, Germany   MedicalResearch.com: What is the background for this study? Response: Breast cancer is a significant public health problem, being the most commonly diagnosed cancer and the second leading cause of cancer death in women in the US. Breast cancer screening from age 50 has been associated with a reduction in mortality and is recommended by the US Preventive Services Task Force. However, there is a significant disparity in mortality rates between Black and White individuals, with Black women having a higher death rate, especially before age 50. The current one-size-fits-all policy for breast cancer screening may not be equitable or optimal, and risk-adapted starting ages of screening based on known risk factors, such as race and ethnicity, may be recommended to optimize the benefit of screening. Our study aimed to provide evidence for a risk-adapted starting age of screening by race and ethnicity.
Author Interviews, Breast Cancer, Mammograms / 07.12.2022

MedicalResearch.com Interview with: [caption id="attachment_59804" align="alignleft" width="150"]Wendie Berg, MD, PhD, FACRProfessor of Radiology University of Pittsburgh Dr. Berg[/caption] Wendie Berg, MD, PhD, FACR Professor of Radiology University of Pittsburgh MedicalResearch.com: What is the background for this study? Response: Mammography misses many cancers in women with a personal history of breast cancer (PHBC). MRI improves early detection of cancer in women with PHBC and the American College of Radiology recommends adding MRI every year for women with PHBC and dense breasts or diagnosis by age 50 but not every woman can tolerate MRI. Contrast-enhanced mammography (CEM) appears to be a good alternative to MRI.  Our study examined performance of CEM after tomosynthesis in women with PHBC.  We first trained our radiologists in CEM (Berg WA et al JBI 2021) and two radiologists interpreted both tomosynthesis and CEM on every participant.